Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Alexamorelin 100–300 mcg Ipamorelin Frequency Multiple times daily Administration Subcutaneous injection Cycle Length 4-6 weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Moderate human trials (Phase 1-2) Efficac

This comparison does not assign a generated winner or score.

  • Dose Range
  • Alexamorelin
  • 100–300 mcg
  • Ipamorelin
  • Frequency
  • Multiple times daily
  • Administration
  • Subcutaneous injection
  • Cycle Length
  • 4-6 weeks
  • 8-12 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Limited human trials
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material